anmelden
SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.04.21 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.04.21 | Novartis Underweight | Barclays Capital | |
| 27.04.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 27.04.21 | Novartis buy | UBS AG | |
| 27.04.21 | Novartis market-perform | Bernstein Research | |
| 23.04.21 | Roche buy | Goldman Sachs Group Inc. | |
| 23.04.21 | Roche Halten | DZ BANK | |
| 23.04.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 22.04.21 | Roche Neutral | Credit Suisse Group | |
| 22.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 22.04.21 | Roche Neutral | Credit Suisse Group | |
| 21.04.21 | Roche Hold | Jefferies & Company Inc. | |
| 21.04.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.04.21 | Roche overweight | Barclays Capital | |
| 21.04.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 21.04.21 | Roche Outperform | Bernstein Research | |
| 19.04.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 09.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 07.04.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 07.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 24.03.21 | Roche overweight | Barclays Capital | |
| 24.03.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 24.03.21 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 23.03.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 23.03.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 23.03.21 | Novartis buy | Jefferies & Company Inc. | |
| 23.03.21 | Novartis market-perform | Bernstein Research | |
| 23.03.21 | Roche Outperform | Bernstein Research | |
| 23.03.21 | Roche Neutral | UBS AG | |
| 23.03.21 | Roche Hold | Deutsche Bank AG | |
| 23.03.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.03.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.03.21 | Roche overweight | Barclays Capital | |
| 22.03.21 | Novartis market-perform | Bernstein Research | |
| 22.03.21 | Roche Neutral | UBS AG | |
| 22.03.21 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 22.03.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 16.03.21 | Roche Hold | Jefferies & Company Inc. | |
| 15.03.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. |